Sold as Cupric Chloride In Plastic Container. Every FDA application for this active ingredient: 1 branded and 4 generic.
As of Nov 16, 2026, FDA lists 5 applications for Cupric Chloride (sold as Cupric Chloride In Plastic Container), first approved Jun 26, 1986, with 0 new uses approved and 0 published complete response letters.
| Jun 26, 1986 | Cupric Chloride In Plastic ContainerNDA 18960 ยท New formulation or manufacturer | Hospira | 13 | Marketed |
| Oct 31, 2022 | Cupric ChlorideANDA 212071 | Exela Pharma | 0 | Marketed |
| Apr 30, 2024 | Cupric ChlorideANDA 216113 | Somerset | 0 | Marketed |
| Apr 30, 2024 | Cupric ChlorideANDA 217626 | Stira | 0 | Marketed |
| Jan 26, 2026 | Cupric ChlorideANDA 217287 | Amneal | 0 | Discontinued |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA